-
1
-
-
84855961822
-
MART-1-and gp100-expressing and -non-expressing melanoma cells are equally proliferative in tumors and clonogenic in vitro
-
Aris, M., Zubieta, M. R., Colombo, M., Arriaga, J. M., Bianchini, M., Alperovich, M., Bravo, A. I., Barrio, M. M., and Mordoh, J. (2012). MART-1-and gp100-expressing and -non-expressing melanoma cells are equally proliferative in tumors and clonogenic in vitro. J. Invest. Dermatol. 132, 365-374.
-
(2012)
J. Invest. Dermatol.
, vol.132
, pp. 365-374
-
-
Aris, M.1
Zubieta, M.R.2
Colombo, M.3
Arriaga, J.M.4
Bianchini, M.5
Alperovich, M.6
Bravo, A.I.7
Barrio, M.M.8
Mordoh, J.9
-
2
-
-
81055127514
-
Anti-CTLA4 mon-oclonal antibodies: the past and the future in clinical application
-
Ascierto, P. A., Marincola, F. M., and Ribas, A. (2011). Anti-CTLA4 mon-oclonal antibodies: the past and the future in clinical application. J. Transl. Med. 9, 196.
-
(2011)
J. Transl. Med.
, vol.9
, pp. 196
-
-
Ascierto, P.A.1
Marincola, F.M.2
Ribas, A.3
-
3
-
-
24944459890
-
Autoimmu-nity correlates with tumor regres-sion in patients with metasta-tic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4
-
Attia, P., Phan, G. Q., Maker, A. V., Robinson, M. R., Quezado, M. M., Yang, J. C., Sherry, R. M., Topalian, S. L., Kammula, U. S., Royal, R. E., Restifo, N. P., Haworth, L. R., Levy, C., Mavroukakis, S. A., Nichol, G., Yellin, M. J., and Rosenberg, S. A. (2005). Autoimmu-nity correlates with tumor regres-sion in patients with metasta-tic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J. Clin. Oncol. 23, 6043-6053.
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 6043-6053
-
-
Attia, P.1
Phan, G.Q.2
Maker, A.V.3
Robinson, M.R.4
Quezado, M.M.5
Yang, J.C.6
Sherry, R.M.7
Topalian, S.L.8
Kammula, U.S.9
Royal, R.E.10
Restifo, N.P.11
Haworth, L.R.12
Levy, C.13
Mavroukakis, S.A.14
Nichol, G.15
Yellin, M.J.16
Rosenberg, S.A.17
-
4
-
-
33645225168
-
The use of oil adjuvants in therapeutic vaccines
-
S2-44-S2-45
-
Aucouturier, J., Ascarateil, S., and Dupuis, L. (2006). The use of oil adjuvants in therapeutic vaccines. Vaccine 24(Suppl. 2), S2-44-S2-45.
-
(2006)
Vaccine
, vol.24
, Issue.SUPPL. 2
-
-
Aucouturier, J.1
Ascarateil, S.2
Dupuis, L.3
-
5
-
-
0344299189
-
Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous
-
Bachmann, M. F., Kohler, G., Ecabert, B., Mak, T. W., and Kopf, M. (1999). Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128-1131.
-
(1999)
J. Immunol.
, vol.163
, pp. 1128-1131
-
-
Bachmann, M.F.1
Kohler, G.2
Ecabert, B.3
Mak, T.W.4
Kopf, M.5
-
6
-
-
33747879399
-
A phase I study of an allogeneic cell vac-cine (VACCIMEL) with GM-CSF in melanoma patients
-
Barrio,M. M.,De Motta,P. T.,Kaplan,J., Von Euw, E. M., Bravo, A. I., Chacon, R. D.,and Mordoh,J. (2006).A phase I study of an allogeneic cell vac-cine (VACCIMEL) with GM-CSF in melanoma patients. J. Immunother. 29, 444-454.
-
(2006)
J. Immunother.
, vol.29
, pp. 444-454
-
-
Barrio, M.M.1
De Motta, P.T.2
Kaplan, J.3
Von Euw, E.M.4
Bravo, A.I.5
Chacon, R.D.6
Mordoh, J.7
-
7
-
-
0023785002
-
Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide
-
Berd, D., and Mastrangelo, M. J. (1988a). Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide. Cancer Invest. 6, 337-349.
-
(1988)
Cancer Invest
, vol.6
, pp. 337-349
-
-
Berd, D.1
Mastrangelo, M.J.2
-
8
-
-
0023930413
-
Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+ 2H4+ suppressor-inducer T-cells
-
Berd, D., and Mastrangelo, M. J. (1988b). Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells. Cancer Res. 48, 1671-1675.
-
(1988)
Cancer Res
, vol.48
, pp. 1671-1675
-
-
Berd, D.1
Mastrangelo, M.J.2
-
9
-
-
49649114804
-
Phase I safety and pharmacokinetic study of CT-011 a humanized antibody inter-acting with PD-1, in patients with advanced hematologic malignan-cies
-
Berger, R., Rotem-Yehudar, R., Slama, G., Landes, S., Kneller, A., Leiba, M., Koren-Michowitz, M., Shimoni, A., and Nagler, A. (2008). Phase I safety and pharmacokinetic study of CT-011, a humanized antibody inter-acting with PD-1, in patients with advanced hematologic malignan-cies. Clin. Cancer Res. 14,3044-3051.
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 3044-3051
-
-
Berger, R.1
Rotem-Yehudar, R.2
Slama, G.3
Landes, S.4
Kneller, A.5
Leiba, M.6
Koren-Michowitz, M.7
Shimoni, A.8
Nagler, A.9
-
10
-
-
0035217962
-
Modes of action of Freund's adju-vants in experimental models of autoimmune diseases
-
Billiau, A., and Matthys, P. (2001). Modes of action of Freund's adju-vants in experimental models of autoimmune diseases. J. Leukoc. Biol. 70, 849-860.
-
(2001)
J. Leukoc. Biol.
, vol.70
, pp. 849-860
-
-
Billiau, A.1
Matthys, P.2
-
11
-
-
77954899030
-
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
-
Brahmer, J. R., Drake, C. G., Woll-ner, I., Powderly, J. D., Picus, J., Sharfman, W. H., Stankevich, E., Pons, A., Salay, T. M., Mcmiller, T. L., Gilson, M. M., Wang, C., Selby, M., Taube, J. M., Anders, R., Chen, L., Korman, A. J., Pardoll, D. M., Lowy, I., and Topalian, S. L. (2010). Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J. Clin. Oncol. 28, 3167-3175.
-
(2010)
J. Clin. Oncol.
, vol.28
, pp. 3167-3175
-
-
Brahmer, J.R.1
Drake, C.G.2
Woll-ner, I.3
Powderly, J.D.4
Picus, J.5
Sharfman, W.H.6
Stankevich, E.7
Pons, A.8
Salay, T.M.9
Mcmiller, T.L.10
Gilson, M.M.11
Wang, C.12
Selby, M.13
Taube, J.M.14
Anders, R.15
Chen, L.16
Korman, A.J.17
Pardoll, D.M.18
Lowy, I.19
Topalian, S.L.20
more..
-
12
-
-
0027165558
-
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
-
Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. (1993). The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178, 489-495.
-
(1993)
J. Exp. Med.
, vol.178
, pp. 489-495
-
-
Brichard, V.1
Van Pel, A.2
Wolfel, T.3
Wolfel, C.4
De Plaen, E.5
Lethe, B.6
Coulie, P.7
Boon, T.8
-
13
-
-
84857725402
-
Exploiting the mutanome for tumor vaccination
-
Castle, J. C., Kreiter, S., Diekmann, J., Lower, M., Van De Roemer, N., De Graaf, J., Selmi, A., Diken, M., Boegel, S., Paret, C., Koslowski, M., Kuhn, A. N., Britten, C. M., Huber, C., Tureci, O., and Sahin, U. (2012). Exploiting the mutanome for tumor vaccination. Cancer Res. 72, 1081-1091.
-
(2012)
Cancer Res
, vol.72
, pp. 1081-1091
-
-
Castle, J.C.1
Kreiter, S.2
Diekmann, J.3
Lower, M.4
Van De Roemer, N.5
De Graaf, J.6
Selmi, A.7
Diken, M.8
Boegel, S.9
Paret, C.10
Koslowski, M.11
Kuhn, A.N.12
Britten, C.M.13
Huber, C.14
Tureci, O.15
Sahin, U.16
-
14
-
-
33644988431
-
Characteri-zation of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma
-
Cesana, G. C., Deraffele, G., Cohen, S., Moroziewicz, D., Mitcham, J., Stoutenburg, J., Cheung, K., Hes-dorffer, C., Kim-Schulze, S., and Kaufman, H. L. (2006). Characteri-zation of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. J. Clin. Oncol. 24, 1169-1177.
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 1169-1177
-
-
Cesana, G.C.1
Deraffele, G.2
Cohen, S.3
Moroziewicz, D.4
Mitcham, J.5
Stoutenburg, J.6
Cheung, K.7
Hes-dorffer, C.8
Kim-Schulze, S.9
Kaufman, H.L.10
-
15
-
-
0035056017
-
CTLA-4-mediated inhibi-tion in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy
-
Chambers, C. A., Kuhns, M. S., Egen, J. G., and Allison, J. P. (2001). CTLA-4-mediated inhibi-tion in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 19, 565-594.
-
(2001)
Annu. Rev. Immunol.
, vol.19
, pp. 565-594
-
-
Chambers, C.A.1
Kuhns, M.S.2
Egen, J.G.3
Allison, J.P.4
-
16
-
-
24944588572
-
Regula-tory T cells and tumor immunity
-
Chattopadhyay, S., Chakraborty, N. G., and Mukherji, B. (2005). Regula-tory T cells and tumor immunity. Cancer Immunol. Immunother. 54, 1153-1161.
-
(2005)
Cancer Immunol. Immunother.
, vol.54
, pp. 1153-1161
-
-
Chattopadhyay, S.1
Chakraborty, N.G.2
Mukherji, B.3
-
17
-
-
12644276375
-
A testicular antigen aber-rantly expressed in human can-cers detected by autologous anti-body screening
-
Chen, Y. T., Scanlan, M. J., Sahin, U., Tureci, O., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., and Old, L. J. (1997). A testicular antigen aber-rantly expressed in human can-cers detected by autologous anti-body screening. Proc. Natl. Acad. Sci. U.S.A. 94, 1914-1918.
-
(1997)
Proc. Natl. Acad. Sci. U. S. A.
, vol.94
, pp. 1914-1918
-
-
Chen, Y.T.1
Scanlan, M.J.2
Sahin, U.3
Tureci, O.4
Gure, A.O.5
Tsang, S.6
Williamson, B.7
Stockert, E.8
Pfreundschuh, M.9
Old, L.J.10
-
18
-
-
33747332544
-
Malignant melanoma: genetics and therapeutics in the genomic era
-
Chin, L., Garraway, L. A., and Fisher, D. E. (2006). Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev. 20, 2149-2182.
-
(2006)
Genes Dev
, vol.20
, pp. 2149-2182
-
-
Chin, L.1
Garraway, L.A.2
Fisher, D.E.3
-
19
-
-
84873076814
-
Phytol-derived novel isoprenoid immunostimu-lants
-
doi:10.3389/fimmu.2012.00049
-
Chowdhury, R., and Ghosh, S. (2012). Phytol-derived novel isoprenoid immunostimu-lants. Front. Immunol. 3:49. doi:10.3389/fimmu.2012.00049
-
(2012)
Front. Immunol.
, vol.3
, pp. 49
-
-
Chowdhury, R.1
Ghosh, S.2
-
20
-
-
0029925375
-
Prognostic value of tumor infiltrating lympho-cytes in the vertical growth phase of primary cutaneous melanoma
-
Clemente, C. G., Mihm, M. C. Jr., Bufalino, R., Zurrida, S., Collini, P., and Cascinelli,N. (1996). Prognostic value of tumor infiltrating lympho-cytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77, 1303-1310.
-
(1996)
Cancer
, vol.77
, pp. 1303-1310
-
-
Clemente, C.G.1
Mihm Jr, M.C.2
Bufalino, R.3
Zurrida, S.4
Collini, P.5
Cascinelli, N.6
-
21
-
-
77954855212
-
Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination
-
Correll, A., Tuettenberg, A., Becker, C., and Jonuleit, H. (2010). Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination. Exp. Dermatol. 19, e213-e221.
-
(2010)
Exp. Dermatol.
, vol.19
-
-
Correll, A.1
Tuettenberg, A.2
Becker, C.3
Jonuleit, H.4
-
22
-
-
0028303166
-
A new gene coding for a differentiation antigen recog-nized by autologous cytolytic T lym-phocytes on HLA-A2 melanomas
-
Coulie, P. G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., Renauld, J. C., and Boon, T. (1994). A new gene coding for a differentiation antigen recog-nized by autologous cytolytic T lym-phocytes on HLA-A2 melanomas. J. Exp. Med. 180, 35-42.
-
(1994)
J. Exp. Med.
, vol.180
, pp. 35-42
-
-
Coulie, P.G.1
Brichard, V.2
Van Pel, A.3
Wolfel, T.4
Schneider, J.5
Traversari, C.6
Mattei, S.7
De Plaen, E.8
Lurquin, C.9
Szikora, J.P.10
Renauld, J.C.11
Boon, T.12
-
23
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carci-noma fosters immune privilege and predicts reduced survival
-
Curiel,T. J.,Coukos,G.,Zou,L.,Alvarez, X.,Cheng,P.,Mottram,P.,Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., Zhu, Y., Wei, S.,Kryczek,I.,Daniel,B.,Gordon,A., Myers, L., Lackner, A., Disis, M. L., Knutson, K. L., Chen, L., and Zou, W. (2004). Specific recruitment of regulatory T cells in ovarian carci-noma fosters immune privilege and predicts reduced survival. Nat. Med. 10, 942-949.
-
(2004)
Nat. Med.
, vol.10
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
Evdemon-Hogan, M.7
Conejo-Garcia, J.R.8
Zhang, L.9
Burow, M.10
Zhu, Y.11
Wei, S.12
Kryczek, I.13
Daniel, B.14
Gordon, A.15
Myers, L.16
Lackner, A.17
Disis, M.L.18
Knutson, K.L.19
Chen, L.20
Zou, W.21
more..
-
24
-
-
82455172010
-
Therapeutic cancer vaccines: why so few ran-domised phase III studies reflect the initial optimism of phase II studies
-
Dalgleish, A. G. (2011). Therapeutic cancer vaccines: why so few ran-domised phase III studies reflect the initial optimism of phase II studies. Vaccine 29, 8501-8505.
-
(2011)
Vaccine
, vol.29
, pp. 8501-8505
-
-
Dalgleish, A.G.1
-
25
-
-
0027538181
-
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific,and long-lasting anti-tumor immunity
-
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific,and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. U.S.A. 90, 3539-3543.
-
(1993)
Proc. Natl. Acad. Sci. U. S. A.
, vol.90
, pp. 3539-3543
-
-
Dranoff, G.1
Jaffee, E.2
Lazenby, A.3
Golumbek, P.4
Levitsky, H.5
Brose, K.6
Jackson, V.7
Hamada, H.8
Pardoll, D.9
Mulligan, R.C.10
-
26
-
-
78650576197
-
Use of defined TLR ligands as adjuvants within human vaccines
-
Duthie, M. S., Windish, H. P., Fox, C. B., and Reed, S. G. (2011). Use of defined TLR ligands as adjuvants within human vaccines. Immunol. Rev. 239, 178-196.
-
(2011)
Immunol. Rev.
, vol.239
, pp. 178-196
-
-
Duthie, M.S.1
Windish, H.P.2
Fox, C.B.3
Reed, S.G.4
-
27
-
-
0037099545
-
Degeneracy of antigen recognition as the mol-ecular basis for the high frequency of naive A2/Melan-a peptide multi-mer(+) CD8(+) T cells in humans
-
Dutoit,V., Rubio-Godoy,V., Pittet, M. J., Zippelius, A., Dietrich, P. Y., Legal, F. A., Guillaume, P., Romero, P., Cerot-tini,J. C.,Houghten,R.A.,Pinilla,C., and Valmori, D. (2002). Degeneracy of antigen recognition as the mol-ecular basis for the high frequency of naive A2/Melan-a peptide multi-mer(+) CD8(+) T cells in humans. J. Exp. Med. 196, 207-216.
-
(2002)
J. Exp. Med.
, vol.196
, pp. 207-216
-
-
Dutoit, V.1
Rubio-Godoy, V.2
Pittet, M.J.3
Zippelius, A.4
Dietrich, P.Y.5
Legal, F.A.6
Guillaume, P.7
Romero, P.8
Cerot-tini, J.C.9
Houghten, R.A.10
Pinilla, C.11
Valmori, D.12
-
28
-
-
84857440345
-
Reviewing the somatic genetics of melanoma: from current to future analytical approaches
-
Dutton-Regester, K., and Hayward, N. K. (2012). Reviewing the somatic genetics of melanoma: from current to future analytical approaches. Pig-ment Cell Melanoma Res. 25, 144- 154.
-
(2012)
Pig-ment Cell Melanoma Res
, vol.25
, pp. 144-154
-
-
Dutton-Regester, K.1
Hayward, N.K.2
-
29
-
-
0036301503
-
CTLA-4:new insights into its biological function and use in tumor immunotherapy
-
Egen,J. G.,Kuhns,M. S.,andAllison,J. P. (2002). CTLA-4:new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3, 611-618.
-
(2002)
Nat. Immunol.
, vol.3
, pp. 611-618
-
-
Egen, J.G.1
Kuhns, M.S.2
Allison, J.P.3
-
30
-
-
0033565923
-
Biodistribu-tion and vaccine efficiency of murine dendritic cells are dependent on the route of administration
-
Eggert, A. A., Schreurs, M. W., Boer-man, O. C., Oyen, W. J., De Boer, A. J., Punt, C. J., Figdor, C. G., and Adema, G. J. (1999). Biodistribu-tion and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 59, 3340-3345.
-
(1999)
Cancer Res
, vol.59
, pp. 3340-3345
-
-
Eggert, A.A.1
Schreurs, M.W.2
Boer-man, O.C.3
Oyen, W.J.4
De Boer, A.J.5
Punt, C.J.6
Figdor, C.G.7
Adema, G.J.8
-
31
-
-
84867552067
-
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial. Can-cer Immunol
-
doi: 10.1007/s00262-012-1242-4
-
Ellebaek, E., Engell-Noerregaard, L., Iversen, T. Z., Froesig, T. M., Munir, S., Hadrup, S. R., Ander-sen, M. H., and Svane, I. M. (2012). Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial. Can-cer Immunol. Immunother. doi: 10.1007/s00262-012-1242-4
-
(2012)
Immunother
-
-
Ellebaek, E.1
Engell-Noerregaard, L.2
Iversen, T.Z.3
Froesig, T.M.4
Munir, S.5
Hadrup, S.R.6
Ander-sen, M.H.7
Svane, I.M.8
-
32
-
-
60749098288
-
Long-lasting cross-presentation of tumor antigen in human DC
-
Faure, F., Mantegazza, A., Sadaka, C., Sedlik, C., Jotereau, F., and Amigorena, S. (2009). Long-lasting cross-presentation of tumor antigen in human DC. Eur. J. Immunol. 39, 380-390.
-
(2009)
Eur. J. Immunol.
, vol.39
, pp. 380-390
-
-
Faure, F.1
Mantegazza, A.2
Sadaka, C.3
Sedlik, C.4
Jotereau, F.5
Amigorena, S.6
-
33
-
-
84965157146
-
Antigenic proper-ties of methylcholanthrene-induced tumors in mice of the strain of origin
-
Foley, E. J. (1953). Antigenic proper-ties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 13, 835-837.
-
(1953)
Cancer Res
, vol.13
, pp. 835-837
-
-
Foley, E.J.1
-
34
-
-
75749152896
-
Struc-ture and function of programmed death (PD) molecules
-
Folkl, A., and Bienzle, D. (2010). Struc-ture and function of programmed death (PD) molecules.Vet. Immunol. Immunopathol. 134, 33-38.
-
(2010)
Vet. Immunol. Immunopathol.
, vol.134
, pp. 33-38
-
-
Folkl, A.1
Bienzle, D.2
-
35
-
-
0037385330
-
Foxp3 pro-grams the development and func-tion of CD4+CD25+ regulatory T cells
-
Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003). Foxp3 pro-grams the development and func-tion of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336.
-
(2003)
Nat. Immunol.
, vol.4
, pp. 330-336
-
-
Fontenot, J.D.1
Gavin, M.A.2
Rudensky, A.Y.3
-
36
-
-
77953641641
-
Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit dis-tinct T cell repertoire
-
Fourcade, J., Sun, Z., Kudela, P., Janjic, B., Kirkwood, J. M., El-Hafnawy, T., and Zarour, H. M. (2010). Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit dis-tinct T cell repertoire. J. Immunol. 184, 6709-6718.
-
(2010)
J. Immunol.
, vol.184
, pp. 6709-6718
-
-
Fourcade, J.1
Sun, Z.2
Kudela, P.3
Janjic, B.4
Kirkwood, J.M.5
El-Hafnawy, T.6
Zarour, H.M.7
-
37
-
-
81955160717
-
Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions
-
Fox, C. B., Baldwin, S. L., Duthie, M. S., Reed, S. G., and Vedvick, T. S. (2011). Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions. Vaccine 29, 9563-9572.
-
(2011)
Vaccine
, vol.29
, pp. 9563-9572
-
-
Fox, C.B.1
Baldwin, S.L.2
Duthie, M.S.3
Reed, S.G.4
Vedvick, T.S.5
-
38
-
-
77049248972
-
The mode of action of immunologic adjuvants
-
Freund, J. (1956). The mode of action of immunologic adjuvants. Bibl. Tuberc. 10, 130-148.
-
(1956)
Bibl. Tuberc.
, vol.10
, pp. 130-148
-
-
Freund, J.1
-
39
-
-
0042884327
-
Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo
-
Garg, S., Oran, A., Wajchman, J., Sasaki, S., Maris, C. H., Kapp, J. A., and Jacob, J. (2003). Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat. Immunol. 4, 907-912.
-
(2003)
Nat. Immunol.
, vol.4
, pp. 907-912
-
-
Garg, S.1
Oran, A.2
Wajchman, J.3
Sasaki, S.4
Maris, C.H.5
Kapp, J.A.6
Jacob, J.7
-
40
-
-
1642378018
-
CD4+CD25 + regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
-
Ghiringhelli, F., Larmonier, N., Schmitt, E., Parcellier, A., Cathelin, D., Gar-rido, C., Chauffert, B., Solary, E., Bonnotte, B., and Martin, F. (2004). CD4+CD25 + regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur. J. Immunol. 34, 336-344.
-
(2004)
Eur. J. Immunol.
, vol.34
, pp. 336-344
-
-
Ghiringhelli, F.1
Larmonier, N.2
Schmitt, E.3
Parcellier, A.4
Cathelin, D.5
Gar-rido, C.6
Chauffert, B.7
Solary, E.8
Bonnotte, B.9
Martin, F.10
-
41
-
-
33847368549
-
Metro-nomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
-
Ghiringhelli, F., Menard, C., Puig, P. E., Ladoire, S., Roux, S., Martin, F., Solary, E., Le Cesne, A., Zitvogel, L., and Chauffert, B. (2007). Metro-nomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol. Immunother. 56, 641-648.
-
(2007)
Cancer Immunol. Immunother.
, vol.56
, pp. 641-648
-
-
Ghiringhelli, F.1
Menard, C.2
Puig, P.E.3
Ladoire, S.4
Roux, S.5
Martin, F.6
Solary, E.7
Le Cesne, A.8
Zitvogel, L.9
Chauffert, B.10
-
42
-
-
58149153043
-
MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell trans-fer efficiency
-
Godet, Y., Moreau-Aubry, A., Guilloux, Y.,Vignard,V.,Khammari,A.,Dreno, B., Jotereau, F., and Labarriere, N. (2008). MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell trans-fer efficiency. J. Exp. Med. 205, 2673-2682.
-
(2008)
J. Exp. Med.
, vol.205
, pp. 2673-2682
-
-
Godet, Y.1
Moreau-Aubry, A.2
Guilloux, Y.3
Vignard, V.4
Khammari, A.5
Dreno, B.6
Jotereau, F.7
Labarriere, N.8
-
43
-
-
0344585451
-
Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma
-
Goldszmid, R. S., Idoyaga, J., Bravo, A. I., Steinman, R., Mordoh, J., and Wainstok, R. (2003). Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J. Immunol. 171, 5940-5947.
-
(2003)
J. Immunol.
, vol.171
, pp. 5940-5947
-
-
Goldszmid, R.S.1
Idoyaga, J.2
Bravo, A.I.3
Steinman, R.4
Mordoh, J.5
Wainstok, R.6
-
44
-
-
33847220364
-
Melanoma biol-ogy and new targeted therapy
-
Gray-Schopfer, V., Wellbrock, C., and Marais, R. (2007). Melanoma biol-ogy and new targeted therapy. Nature 445, 851-857.
-
(2007)
Nature
, vol.445
, pp. 851-857
-
-
Gray-Schopfer, V.1
Wellbrock, C.2
Marais, R.3
-
45
-
-
0036180686
-
CTLA-4 reg-ulates cell cycle progression during a primary immune response
-
Greenwald, R. J., Oosterwegel, M. A., Van Der Woude, D., Kubal, A., Man-delbrot, D. A., Boussiotis, V. A., and Sharpe, A. H. (2002). CTLA-4 reg-ulates cell cycle progression during a primary immune response. Eur. J. Immunol. 32, 366-373.
-
(2002)
Eur. J. Immunol.
, vol.32
, pp. 366-373
-
-
Greenwald, R.J.1
Oosterwegel, M.A.2
Van Der Woude, D.3
Kubal, A.4
Man-delbrot, D.A.5
Boussiotis, V.A.6
Sharpe, A.H.7
-
46
-
-
0034614637
-
The hallmarks of cancer
-
Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
-
(2000)
Cell
, vol.100
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
47
-
-
0742269426
-
Phase I/II study of treatment with dendritic cell vac-cines in patients with dissemi-nated melanoma
-
Hersey, P., Menzies, S. W., Hall-iday, G. M., Nguyen, T., Far-relly, M. L., Desilva, C., and Lett, M. (2004). Phase I/II study of treatment with dendritic cell vac-cines in patients with dissemi-nated melanoma. Cancer Immunol. Immunother. 53, 125-134.
-
(2004)
Cancer Immunol. Immunother.
, vol.53
, pp. 125-134
-
-
Hersey, P.1
Menzies, S.W.2
Hall-iday, G.M.3
Nguyen, T.4
Far-relly, M.L.5
Desilva, C.6
Lett, M.7
-
48
-
-
35748930538
-
Leukocyte infiltration and tumor cell plastic-ity are parameters of aggressiveness in primary cutaneous melanoma
-
Hillen, F., Baeten, C. I., Van De Winkel, A., Creytens, D., Van Der Schaft, D. W., Winnepenninckx, V., and Griffioen, A. W. (2008). Leukocyte infiltration and tumor cell plastic-ity are parameters of aggressiveness in primary cutaneous melanoma. Cancer Immunol. Immunother. 57, 97-106.
-
(2008)
Cancer Immunol. Immunother.
, vol.57
, pp. 97-106
-
-
Hillen, F.1
Baeten, C.I.2
Van De Winkel, A.3
Creytens, D.4
Van Der Schaft, D.W.5
Winnepenninckx, V.6
Griffioen, A.W.7
-
49
-
-
42949105127
-
Immunologic and clini-cal effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
-
Hodi, F. S., Butler, M., Oble, D. A., Sei-den, M. V., Haluska, F. G., Kruse, A., Macrae, S., Nelson, M., Canning, C., Lowy, I., Korman, A., Lautz, D., Russell, S., Jaklitsch, M. T., Ramaiya, N., Chen, T. C., Neuberg, D., Alli-son, J. P., Mihm, M. C., and Dranoff, G. (2008). Immunologic and clini-cal effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc. Natl. Acad. Sci. U.S.A. 105, 3005-3010.
-
(2008)
Proc. Natl. Acad. Sci. U. S. A.
, vol.105
, pp. 3005-3010
-
-
Hodi, F.S.1
Butler, M.2
Oble, D.A.3
Sei-den, M.V.4
Haluska, F.G.5
Kruse, A.6
Macrae, S.7
Nelson, M.8
Canning, C.9
Lowy, I.10
Korman, A.11
Lautz, D.12
Russell, S.13
Jaklitsch, M.T.14
Ramaiya, N.15
Chen, T.C.16
Neuberg, D.17
Alli-son, J.P.18
Mihm, M.C.19
Dranoff, G.20
more..
-
50
-
-
0344341626
-
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
-
Hodi, F. S., Mihm, M. C., Soiffer, R. J., Haluska, F. G., Butler, M., Seiden, M. V., Davis, T., Henry-Spires, R., Macrae, S., Willman, A., Padera, R., Jaklitsch, M. T., Shankar, S., Chen, T. C., Korman, A., Allison, J. P., and Dranoff, G. (2003). Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc. Natl. Acad. Sci. U.S.A. 100, 4712-4717.
-
(2003)
Proc. Natl. Acad. Sci. U. S. A.
, vol.100
, pp. 4712-4717
-
-
Hodi, F.S.1
Mihm, M.C.2
Soiffer, R.J.3
Haluska, F.G.4
Butler, M.5
Seiden, M.V.6
Davis, T.7
Henry-Spires, R.8
Macrae, S.9
Willman, A.10
Padera, R.11
Jaklitsch, M.T.12
Shankar, S.13
Chen, T.C.14
Korman, A.15
Allison, J.P.16
Dranoff, G.17
-
51
-
-
77954801079
-
Improved survival with ipil-imumab in patients with metasta-tic melanoma
-
Hodi, F. S., O'Day, S. J., Mcdermott, D. F., Weber, R. W., Sosman, J. A., Haa-nen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., Aker-ley, W., Van Den Eertwegh, A. J., Lutzky, J., Lorigan, P., Vaubel, J. M., Linette, G. P., Hogg, D., Ottensmeier, C. H., Lebbe, C., Peschel, C., Quirt, I., Clark, J. I., Wolchok, J. D., Weber, J. S., Tian, J., Yellin, M. J., Nichol, G. M., Hoos, A., and Urba, W. J. (2010). Improved survival with ipil-imumab in patients with metasta-tic melanoma. N.Engl.J.Med.363, 711-723.
-
(2010)
N. Engl. J. Med.
, vol.363
, pp. 711-723
-
-
Hodi, F.S.1
O'Day, S.J.2
Mcdermott, D.F.3
Weber, R.W.4
Sosman, J.A.5
Haa-nen, J.B.6
Gonzalez, R.7
Robert, C.8
Schadendorf, D.9
Hassel, J.C.10
Aker-ley, W.11
Van Den Eertwegh, A.J.12
Lutzky, J.13
Lorigan, P.14
Vaubel, J.M.15
Linette, G.P.16
Hogg, D.17
Ottensmeier, C.H.18
Lebbe, C.19
Peschel, C.20
Quirt, I.21
Clark, J.I.22
Wolchok, J.D.23
Weber, J.S.24
Tian, J.25
Yellin, M.J.26
Nichol, G.M.27
Hoos, A.28
Urba, W.J.29
more..
-
52
-
-
79959206459
-
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regard-less of clinical responses in humans
-
Huang, R. R., Jalil, J., Economou, J. S., Chmielowski, B., Koya, R. C., Mok, S., Sazegar, H., Seja, E., Villanueva, A., Gomez-Navarro, J., Glaspy, J. A., Cochran, A. J., and Ribas, A. (2011). CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regard-less of clinical responses in humans. Clin. Cancer Res. 17, 4101-4109.
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 4101-4109
-
-
Huang, R.R.1
Jalil, J.2
Economou, J.S.3
Chmielowski, B.4
Koya, R.C.5
Mok, S.6
Sazegar, H.7
Seja, E.8
Villanueva, A.9
Gomez-Navarro, J.10
Glaspy, J.A.11
Cochran, A.J.12
Ribas, A.13
-
53
-
-
84857397717
-
Interdis-ciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer
-
Huber, M. L., Haynes, L., Parker, C., and Iversen, P. (2012). Interdis-ciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer. J. Natl. Cancer Inst. 104, 273-279.
-
(2012)
J. Natl. Cancer Inst.
, vol.104
, pp. 273-279
-
-
Huber, M.L.1
Haynes, L.2
Parker, C.3
Iversen, P.4
-
54
-
-
16544383331
-
Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity
-
Hugues, S., Fetler, L., Bonifaz, L., Helft, J., Amblard, F., and Amigorena, S. (2004). Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat. Immunol. 5, 1235-1242.
-
(2004)
Nat. Immunol.
, vol.5
, pp. 1235-1242
-
-
Hugues, S.1
Fetler, L.2
Bonifaz, L.3
Helft, J.4
Amblard, F.5
Amigorena, S.6
-
55
-
-
84855338629
-
Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
-
Jacobs, J. F., Nierkens, S., Figdor, C. G., De Vries, I. J., and Adema, G. J. (2012). Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy? Lancet Oncol. 13, e32-e42.
-
(2012)
Lancet Oncol
, vol.13
-
-
Jacobs, J.F.1
Nierkens, S.2
Figdor, C.G.3
De Vries, I.J.4
Adema, G.J.5
-
56
-
-
77958056009
-
Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients
-
Jacobs, J. F., Punt, C. J., Lesterhuis, W. J., Sutmuller, R. P., Brouwer, H. M., Scharenborg, N. M., Klasen, I. S., Hilbrands, L. B., Figdor, C. G., De Vries, I. J., and Adema, G. J. (2010). Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients. Clin. Cancer Res. 16, 5067-5078.
-
(2010)
Clin. Cancer Res.
, vol.16
, pp. 5067-5078
-
-
Jacobs, J.F.1
Punt, C.J.2
Lesterhuis, W.J.3
Sutmuller, R.P.4
Brouwer, H.M.5
Scharenborg, N.M.6
Klasen, I.S.7
Hilbrands, L.B.8
Figdor, C.G.9
De Vries, I.J.10
Adema, G.J.11
-
57
-
-
52549083059
-
Selec-tive accumulation of differenti-ated FOXP3(+) CD4(+) T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood
-
Jandus, C., Bioley, G., Speiser, D. E., and Romero, P. (2008). Selec-tive accumulation of differenti-ated FOXP3(+) CD4(+) T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood. Cancer Immunol. Immunother. 57, 1795-1805.
-
(2008)
Cancer Immunol. Immunother.
, vol.57
, pp. 1795-1805
-
-
Jandus, C.1
Bioley, G.2
Speiser, D.E.3
Romero, P.4
-
58
-
-
0037217371
-
CD4+CD25+ suppressor lympho-cytes in the circulation of patients immunized against melanoma anti-gens
-
Javia, L. R., and Rosenberg, S. A. (2003). CD4+CD25+ suppressor lympho-cytes in the circulation of patients immunized against melanoma anti-gens. J. Immunother. 26, 85-93.
-
(2003)
J. Immunother.
, vol.26
, pp. 85-93
-
-
Javia, L.R.1
Rosenberg, S.A.2
-
59
-
-
77955066199
-
Sipuleucel-T immunotherapy for castration-resistant prostate cancer
-
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Fer-rari, A. C., Dreicer, R., Sims, R. B., Xu, Y., Frohlich, M. W., and Schell-hammer, P. F. (2010). Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 363, 411-422.
-
(2010)
N. Engl. J. Med.
, vol.363
, pp. 411-422
-
-
Kantoff, P.W.1
Higano, C.S.2
Shore, N.D.3
Berger, E.R.4
Small, E.J.5
Penson, D.F.6
Redfern, C.H.7
Fer-rari, A.C.8
Dreicer, R.9
Sims, R.B.10
Xu, Y.11
Frohlich, M.W.12
Schell-hammer, P.F.13
-
60
-
-
0028316911
-
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
-
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosen-berg, S. A. (1994a). Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. U.S.A. 91, 3515-3519.
-
(1994)
Proc. Natl. Acad. Sci. U. S. A.
, vol.91
, pp. 3515-3519
-
-
Kawakami, Y.1
Eliyahu, S.2
Delgado, C.H.3
Robbins, P.F.4
Rivoltini, L.5
Topalian, S.L.6
Miki, T.7
Rosen-berg, S.A.8
-
61
-
-
0028298174
-
Identification of a human melanoma antigen recog-nized by tumor-infiltrating lym-phocytes associated with in vivo tumor rejection
-
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A. (1994b). Identification of a human melanoma antigen recog-nized by tumor-infiltrating lym-phocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. U.S.A. 91, 6458-6462.
-
(1994)
Proc. Natl. Acad. Sci. U. S. A.
, vol.91
, pp. 6458-6462
-
-
Kawakami, Y.1
Eliyahu, S.2
Delgado, C.H.3
Robbins, P.F.4
Sakaguchi, K.5
Appella, E.6
Yannelli, J.R.7
Adema, G.J.8
Miki, T.9
Rosenberg, S.A.10
-
62
-
-
42649125225
-
PD-1 and its ligands in tolerance and immunity
-
Keir, M. E., Butte, M. J., Freeman, G. J., and Sharpe, A. H. (2008). PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26, 677-704.
-
(2008)
Annu. Rev. Immunol.
, vol.26
, pp. 677-704
-
-
Keir, M.E.1
Butte, M.J.2
Freeman, G.J.3
Sharpe, A.H.4
-
63
-
-
0031661414
-
QS-21: a water-soluble triterpene glycoside adjuvant
-
Kensil, C. R., and Kammer, R. (1998). QS-21: a water-soluble triterpene glycoside adjuvant. Expert Opin. Investig. Drugs 7, 1475-1482.
-
(1998)
Expert Opin. Investig. Drugs
, vol.7
, pp. 1475-1482
-
-
Kensil, C.R.1
Kammer, R.2
-
64
-
-
37249067503
-
CD8+ Foxp3+ regulatory T cells mediate immuno-suppression in prostate cancer
-
Kiniwa, Y., Miyahara, Y., Wang, H. Y., Peng, W., Peng, G., Wheeler, T. M., Thompson, T. C., Old, L. J., and Wang, R. F. (2007). CD8+ Foxp3+ regulatory T cells mediate immuno-suppression in prostate cancer. Clin. Cancer Res. 13, 6947-6958.
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 6947-6958
-
-
Kiniwa, Y.1
Miyahara, Y.2
Wang, H.Y.3
Peng, W.4
Peng, G.5
Wheeler, T.M.6
Thompson, T.C.7
Old, L.J.8
Wang, R.F.9
-
65
-
-
0035339880
-
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801
-
Kirkwood, J. M., Ibrahim, J. G., Sos-man, J. A., Sondak, V. K., Agarwala, S. S., Ernstoff, M. S., and Rao, U. (2001). High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J. Clin. Oncol. 19, 2370-2380.
-
(2001)
J. Clin. Oncol.
, vol.19
, pp. 2370-2380
-
-
Kirkwood, J.M.1
Ibrahim, J.G.2
Sos-man, J.A.3
Sondak, V.K.4
Agarwala, S.S.5
Ernstoff, M.S.6
Rao, U.7
-
66
-
-
79954621235
-
Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metasta-tic melanoma
-
Knol, A. C., Nguyen, J. M., Quereux, G., Brocard, A., Khammari, A., and Dreno, B. (2011). Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metasta-tic melanoma. Exp. Dermatol. 20, 430-434.
-
(2011)
Exp. Dermatol.
, vol.20
, pp. 430-434
-
-
Knol, A.C.1
Nguyen, J.M.2
Quereux, G.3
Brocard, A.4
Khammari, A.5
Dreno, B.6
-
67
-
-
36849010167
-
Adaptive immunity main-tains occult cancer in an equilibrium state
-
Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., and Schreiber, R. D. (2007). Adaptive immunity main-tains occult cancer in an equilibrium state. Nature 450, 903-907.
-
(2007)
Nature
, vol.450
, pp. 903-907
-
-
Koebel, C.M.1
Vermi, W.2
Swann, J.B.3
Zerafa, N.4
Rodig, S.J.5
Old, L.J.6
Smyth, M.J.7
Schreiber, R.D.8
-
68
-
-
77956883758
-
FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma
-
Ladanyi, A., Mohos, A., Somlai, B., Liszkay, G., Gilde, K., Fejos, Z., Gaudi, I., and Timar, J. (2010). FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma. Pathol. Oncol. Res. 16, 303-309.
-
(2010)
Pathol. Oncol. Res.
, vol.16
, pp. 303-309
-
-
Ladanyi, A.1
Mohos, A.2
Somlai, B.3
Liszkay, G.4
Gilde, K.5
Fejos, Z.6
Gaudi, I.7
Timar, J.8
-
69
-
-
0030595339
-
The dorsoven-tral regulatory gene cassette spat-zle/Toll/cactus controls the potent antifungal response in Drosophila adults
-
Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M., and Hoff-mann, J. A. (1996). The dorsoven-tral regulatory gene cassette spat-zle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983.
-
(1996)
Cell
, vol.86
, pp. 973-983
-
-
Lemaitre, B.1
Nicolas, E.2
Michaut, L.3
Reichhart, J.M.4
Hoff-mann, J.A.5
-
70
-
-
84873315606
-
Cumulative autoimmu-nity: T cell clones recognizing sev-eral self-epitopes exhibit enhanced pathogenicity
-
doi:10.3389/fimmu.2011.00047
-
Liblau, R., Wekerle, H., and Tisch, R. (2011). Cumulative autoimmu-nity: T cell clones recognizing sev-eral self-epitopes exhibit enhanced pathogenicity. Front. Immunol. 2:47. doi:10.3389/fimmu.2011.00047
-
(2011)
Front. Immunol.
, vol.2
, pp. 47
-
-
Liblau, R.1
Wekerle, H.2
Tisch, R.3
-
71
-
-
28544431840
-
Innate NKT lymphocytes confer superior adap-tive immunity via tumor-capturing dendritic cells
-
Liu, K., Idoyaga, J., Charalambous, A., Fujii, S., Bonito, A., Mordoh, J., Wainstok, R., Bai, X. F., Liu, Y., and Steinman, R. M. (2005). Innate NKT lymphocytes confer superior adap-tive immunity via tumor-capturing dendritic cells. J. Exp. Med. 202, 1507-1516.
-
(2005)
J. Exp. Med.
, vol.202
, pp. 1507-1516
-
-
Liu, K.1
Idoyaga, J.2
Charalambous, A.3
Fujii, S.4
Bonito, A.5
Mordoh, J.6
Wainstok, R.7
Bai, X.F.8
Liu, Y.9
Steinman, R.M.10
-
72
-
-
0031054219
-
Tumor cell reactivity medi-ated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibod-ies
-
Livingston, P., Zhang, S., Adluri, S., Yao, T. J., Graeber, L., Ragupathi, G., Helling, F., and Fleisher, M. (1997). Tumor cell reactivity medi-ated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibod-ies. Cancer Immunol. Immunother. 43, 324-330.
-
(1997)
Cancer Immunol. Immunother.
, vol.43
, pp. 324-330
-
-
Livingston, P.1
Zhang, S.2
Adluri, S.3
Yao, T.J.4
Graeber, L.5
Ragupathi, G.6
Helling, F.7
Fleisher, M.8
-
73
-
-
84856865635
-
Reg-ulatory T cells: banned cells for decades
-
Loser, K., and Beissert, S. (2012). Reg-ulatory T cells: banned cells for decades. J. Invest. Dermatol. 132, 864-871.
-
(2012)
J. Invest. Dermatol.
, vol.132
, pp. 864-871
-
-
Loser, K.1
Beissert, S.2
-
74
-
-
33644813226
-
Immunogenicity, including vitiligo, and feasibility of vacci-nation with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients
-
Luiten, R. M., Kueter, E. W., Mooi, W., Gallee, M. P., Rankin, E. M., Ger-ritsen, W. R., Clift, S. M., Nooi-jen, W. J., Weder, P., Van De Kas-teele, W. F., Sein, J., Van Den Berk, P. C., Nieweg, O. E., Berns, A. M., Spits, H., and De Gast, G. C. (2005). Immunogenicity, including vitiligo, and feasibility of vacci-nation with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients. J. Clin. Oncol. 23, 8978-8991.
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 8978-8991
-
-
Luiten, R.M.1
Kueter, E.W.2
Mooi, W.3
Gallee, M.P.4
Rankin, E.M.5
Ger-ritsen, W.R.6
Clift, S.M.7
Nooi-jen, W.J.8
Weder, P.9
Van De Kas-teele, W.F.10
Sein, J.11
Van Den Berk, P.C.12
Nieweg, O.E.13
Berns, A.M.14
Spits, H.15
De Gast, G.C.16
-
75
-
-
0030831210
-
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
-
Medzhitov, R., Preston-Hurlburt, P., and Janeway, C. A. Jr. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397.
-
(1997)
Nature
, vol.388
, pp. 394-397
-
-
Medzhitov, R.1
Preston-Hurlburt, P.2
Janeway Jr, C.A.3
-
76
-
-
38449103549
-
Utility of tumour-infiltrating CD25+FOXP3+ regula-tory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma
-
Miracco, C., Mourmouras, V., Biagi-oli, M., Rubegni, P., Mannucci, S., Monciatti, I., Cosci, E., Tosi, P., and Luzi, P. (2007). Utility of tumour-infiltrating CD25+FOXP3+ regula-tory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma. Oncol. Rep. 18, 1115-1122.
-
(2007)
Oncol. Rep.
, vol.18
, pp. 1115-1122
-
-
Miracco, C.1
Mourmouras, V.2
Biagi-oli, M.3
Rubegni, P.4
Mannucci, S.5
Monciatti, I.6
Cosci, E.7
Tosi, P.8
Luzi, P.9
-
77
-
-
0014867646
-
Immuno-logical factors in human sarcomas and melanomas: a rational basis for immunotherapy
-
Morton, D. L., Eilber, F. R., Joseph, W. L., Wood, W. C., Trahan, E., and Ketcham, A. S. (1970). Immuno-logical factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann. Surg. 172, 740-749.
-
(1970)
Ann. Surg.
, vol.172
, pp. 740-749
-
-
Morton, D.L.1
Eilber, F.R.2
Joseph, W.L.3
Wood, W.C.4
Trahan, E.5
Ketcham, A.S.6
-
78
-
-
0014311892
-
Demonstration of antibodies against human malignant melanoma by immunofluorescence
-
Morton,D. L.,Malmgren,R.A.,Holmes, E. C., and Ketcham, A. S. (1968). Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery 64, 233-240.
-
(1968)
Surgery
, vol.64
, pp. 233-240
-
-
Morton, D.L.1
Malmgren, R.A.2
Holmes, E.C.3
Ketcham, A.S.4
-
79
-
-
33846519492
-
Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity
-
Nair, S., Boczkowski, D., Fassnacht, M., Pisetsky, D., and Gilboa, E. (2007). Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Cancer Res. 67, 371-380.
-
(2007)
Cancer Res
, vol.67
, pp. 371-380
-
-
Nair, S.1
Boczkowski, D.2
Fassnacht, M.3
Pisetsky, D.4
Gilboa, E.5
-
80
-
-
77953945438
-
Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs
-
Nakahara, T., Uchi, H., Lesokhin, A. M., Avogadri, F., Rizzuto, G. A., Hirschhorn-Cymerman, D., Panageas, K. S., Merghoub, T., Wolchok, J. D., and Houghton, A. N. (2010). Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs. Blood 115, 4384-4392.
-
(2010)
Blood
, vol.115
, pp. 4384-4392
-
-
Nakahara, T.1
Uchi, H.2
Lesokhin, A.M.3
Avogadri, F.4
Rizzuto, G.A.5
Hirschhorn-Cymerman, D.6
Panageas, K.S.7
Merghoub, T.8
Wolchok, J.D.9
Houghton, A.N.10
-
81
-
-
34547794178
-
PD-1 and PD-1 ligands: from discovery to clinical application
-
Okazaki, T., and Honjo, T. (2007). PD-1 and PD-1 ligands: from discovery to clinical application. Int. Immunol. 19, 813-824.
-
(2007)
Int. Immunol.
, vol.19
, pp. 813-824
-
-
Okazaki, T.1
Honjo, T.2
-
82
-
-
33748693100
-
Dendritic cells loaded with killed allogeneic melanoma cells can induce objec-tive clinical responses and MART-1 specific CD8+ T-cell immunity
-
Palucka, A. K., Ueno, H., Connolly, J., Kerneis-Norvell, F., Blanck, J. P., Johnston, D. A., Fay, J., and Banchereau, J. (2006). Dendritic cells loaded with killed allogeneic melanoma cells can induce objec-tive clinical responses and MART-1 specific CD8+ T-cell immunity. J. Immunother. 29, 545-557.
-
(2006)
J. Immunother.
, vol.29
, pp. 545-557
-
-
Palucka, A.K.1
Ueno, H.2
Connolly, J.3
Kerneis-Norvell, F.4
Blanck, J.P.5
Johnston, D.A.6
Fay, J.7
Banchereau, J.8
-
83
-
-
78651072784
-
Sin-gle dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance
-
Pedicord, V. A., Montalvo, W., Leiner, I. M., and Allison, J. P. (2011). Sin-gle dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance. Proc. Natl. Acad. Sci. U.S.A. 108, 266-271.
-
(2011)
Proc. Natl. Acad. Sci. U. S. A.
, vol.108
, pp. 266-271
-
-
Pedicord, V.A.1
Montalvo, W.2
Leiner, I.M.3
Allison, J.P.4
-
84
-
-
68149155982
-
Cham-bers, C. A., Korman, A. J., and Alli-son, J. P
-
Peggs, K. S., Quezada, S. A., Cham-bers, C. A., Korman, A. J., and Alli-son, J. P. (2009). Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J. Exp. Med. 206, 1717-1725.
-
(2009)
J. Exp. Med.
, vol.206
, pp. 1717-1725
-
-
Peggs, K.S.1
Quezada, S.A.2
-
85
-
-
0032509295
-
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene
-
Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., and Beutler, B. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088.
-
(1998)
Science
, vol.282
, pp. 2085-2088
-
-
Poltorak, A.1
He, X.2
Smirnova, I.3
Liu, M.Y.4
Van Huffel, C.5
Du, X.6
Birdwell, D.7
Alejos, E.8
Silva, M.9
Galanos, C.10
Freudenberg, M.11
Ricciardi-Castagnoli, P.12
Layton, B.13
Beutler, B.14
-
86
-
-
44949111435
-
Par-tial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration
-
Powell, D. J. Jr., Attia, P., Ghetie, V., Schindler, J., Vitetta, E. S., and Rosenberg, S. A. (2008). Par-tial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration. J. Immunother. 31, 189-198.
-
(2008)
J. Immunother.
, vol.31
, pp. 189-198
-
-
Powell Jr, D.J.1
Attia, P.2
Ghetie, V.3
Schindler, J.4
Vitetta, E.S.5
Rosenberg, S.A.6
-
87
-
-
70449193189
-
Immunity to methylcholanthrene-induced sarcomas
-
Prehn, R. T., and Main, J. M. (1957). Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 18, 769-778.
-
(1957)
J. Natl. Cancer Inst.
, vol.18
, pp. 769-778
-
-
Prehn, R.T.1
Main, J.M.2
-
88
-
-
33745851479
-
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratu-mor balance of effector and regu-latory T cells
-
Quezada, S. A., Peggs, K. S., Curran, M. A., and Allison, J. P. (2006). CTLA4 blockade and GM-CSF combination immunotherapy alters the intratu-mor balance of effector and regu-latory T cells. J. Clin. Invest. 116, 1935-1945.
-
(2006)
J. Clin. Invest.
, vol.116
, pp. 1935-1945
-
-
Quezada, S.A.1
Peggs, K.S.2
Curran, M.A.3
Allison, J.P.4
-
89
-
-
79955529454
-
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
-
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., Hou, T. Z., Futter, C. E., Anderson, G., Walker, L. S., and Sansom, D. M. (2011). Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600-603.
-
(2011)
Science
, vol.332
, pp. 600-603
-
-
Qureshi, O.S.1
Zheng, Y.2
Nakamura, K.3
Attridge, K.4
Manzotti, C.5
Schmidt, E.M.6
Baker, J.7
Jeffery, L.E.8
Kaur, S.9
Briggs, Z.10
Hou, T.Z.11
Futter, C.E.12
Anderson, G.13
Walker, L.S.14
Sansom, D.M.15
-
90
-
-
70350108862
-
Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
-
Radojcic, V., Bezak, K. B., Skarica, M., Pletneva, M. A., Yoshimura, K., Schulick, R. D., and Luznik, L. (2010). Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination. Cancer Immunol. Immunother. 59, 137-148.
-
(2010)
Cancer Immunol. Immunother.
, vol.59
, pp. 137-148
-
-
Radojcic, V.1
Bezak, K.B.2
Skarica, M.3
Pletneva, M.A.4
Yoshimura, K.5
Schulick, R.D.6
Luznik, L.7
-
91
-
-
34247493188
-
Nat-urally occurring regulatory T cells: recent insights in health and disease
-
Raimondi, G., Turner, M. S., Thomson, A. W., and Morel, P. A. (2007). Nat-urally occurring regulatory T cells: recent insights in health and disease. Crit. Rev. Immunol. 27, 61-95.
-
(2007)
Crit. Rev. Immunol.
, vol.27
, pp. 61-95
-
-
Raimondi, G.1
Turner, M.S.2
Thomson, A.W.3
Morel, P.A.4
-
92
-
-
77950352572
-
Imaging of CTLA4 blockade-induced cell repli-cation with (18)F-FLT PET in patients with advanced melanoma treated with tremelimumab
-
Ribas, A., Benz, M. R., Allen-Auerbach, M. S., Radu, C., Chmielowski, B., Seja, E., Williams, J. L., Gomez-Navarro, J., Mccarthy, T., and Czernin, J. (2010). Imaging of CTLA4 blockade-induced cell repli-cation with (18)F-FLT PET in patients with advanced melanoma treated with tremelimumab. J. Nucl. Med. 51, 340-346.
-
(2010)
J. Nucl. Med.
, vol.51
, pp. 340-346
-
-
Ribas, A.1
Benz, M.R.2
Allen-Auerbach, M.S.3
Radu, C.4
Chmielowski, B.5
Seja, E.6
Williams, J.L.7
Gomez-Navarro, J.8
Mccarthy, T.9
Czernin, J.10
-
93
-
-
32644467549
-
Antitu-mor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675, 206
-
Ribas, A., Camacho, L. H., Lopez-Berestein, G., Pavlov, D., Bulanhagui, C. A., Millham, R., Comin-Anduix, B., Reuben, J. M., Seja, E., Parker, C. A., Sharma, A., Glaspy, J. A., and Gomez-Navarro, J. (2005). Antitu-mor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206. J. Clin. Oncol. 23, 8968-8977.
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 8968-8977
-
-
Ribas, A.1
Camacho, L.H.2
Lopez-Berestein, G.3
Pavlov, D.4
Bulanhagui, C.A.5
Millham, R.6
Comin-Anduix, B.7
Reuben, J.M.8
Seja, E.9
Parker, C.A.10
Sharma, A.11
Glaspy, J.A.12
Gomez-Navarro, J.13
-
94
-
-
70349680756
-
Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma
-
Ribas, A., Comin-Anduix, B., Chmielowski, B., Jalil, J., De La Rocha, P., Mccannel, T. A., Ochoa, M. T., Seja, E., Villanueva, A., Oseguera, D. K., Straatsma, B. R., Cochran, A. J., Glaspy, J. A., Hui, L., Marincola, F. M., Wang, E., Economou, J. S., and Gomez-Navarro, J. (2009). Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin. Cancer Res. 15, 6267-6276.
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 6267-6276
-
-
Ribas, A.1
Comin-Anduix, B.2
Chmielowski, B.3
Jalil, J.4
De La Rocha, P.5
Mccannel, T.A.6
Ochoa, M.T.7
Seja, E.8
Villanueva, A.9
Oseguera, D.K.10
Straatsma, B.R.11
Cochran, A.J.12
Glaspy, J.A.13
Hui, L.14
Marincola, F.M.15
Wang, E.16
Economou, J.S.17
Gomez-Navarro, J.18
-
95
-
-
79959772576
-
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
-
Robert, C., Thomas, L., Bondarenko, I., O'Day, S. M. D. J., Garbe, C., Lebbe, C., Baurain, J. F., Testori, A., Grob, J. J., Davidson, N., Richards, J., Maio, M., Hauschild, A., Miller, W. H. Jr., Gascon, P., Lotem, M., Harmankaya, K., Ibrahim, R., Francis, S., Chen, T. T., Humphrey, R., Hoos, A., and Wolchok, J. D. (2011). Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N. Engl.J.Med.364, 2517-2526.
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 2517-2526
-
-
Robert, C.1
Thomas, L.2
Bondarenko, I.3
O'Day, S.M.D.J.4
Garbe, C.5
Lebbe, C.6
Baurain, J.F.7
Testori, A.8
Grob, J.J.9
Davidson, N.10
Richards, J.11
Maio, M.12
Hauschild, A.13
Miller Jr, W.H.14
Gascon, P.15
Lotem, M.16
Harmankaya, K.17
Ibrahim, R.18
Francis, S.19
Chen, T.T.20
Humphrey, R.21
Hoos, A.22
Wolchok, J.D.23
more..
-
96
-
-
4644324025
-
Cancer immunother-apy: moving beyond current vac-cines
-
Rosenberg, S. A.,Yang, J. C., and Restifo, N. P. (2004). Cancer immunother-apy: moving beyond current vac-cines. Nat. Med. 10, 909-915.
-
(2004)
Nat. Med.
, vol.10
, pp. 909-915
-
-
Rosenberg, S.A.1
Yang, J.C.2
Restifo, N.P.3
-
97
-
-
80053508491
-
Whole cancer genome sequencing by next-generation methods
-
Ross, J. S., and Cronin, M. (2011). Whole cancer genome sequencing by next-generation methods. Am. J. Clin. Pathol. 136, 527-539.
-
(2011)
Am. J. Clin. Pathol.
, vol.136
, pp. 527-539
-
-
Ross, J.S.1
Cronin, M.2
-
98
-
-
33746336533
-
The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology
-
Sansom, D. M., and Walker, L. S. (2006). The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol. Rev. 212, 131-148.
-
(2006)
Immunol. Rev.
, vol.212
, pp. 131-148
-
-
Sansom, D.M.1
Walker, L.S.2
-
100
-
-
24644506094
-
CTLA-4 up-regulation of lympho-cyte function-associated antigen 1 adhesion and clustering as an alter-nate basis for coreceptor function
-
Schneider, H., Valk, E., Da Rocha Dias, S., Wei, B., and Rudd, C. E. (2005). CTLA-4 up-regulation of lympho-cyte function-associated antigen 1 adhesion and clustering as an alter-nate basis for coreceptor function. Proc. Natl. Acad. Sci. U.S.A. 102, 12861-12866.
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.102
, pp. 12861-12866
-
-
Schneider, H.1
Valk, E.2
Da Rocha Dias, S.3
Wei, B.4
Rudd, C.E.5
-
101
-
-
0021917676
-
Murine epidermal Langerhans cells mature into potent immunostimu-latory dendritic cells in vitro
-
Schuler, G., and Steinman, R. M. (1985). Murine epidermal Langerhans cells mature into potent immunostimu-latory dendritic cells in vitro. J. Exp. Med. 161, 526-546.
-
(1985)
J. Exp. Med.
, vol.161
, pp. 526-546
-
-
Schuler, G.1
Steinman, R.M.2
-
102
-
-
79957831345
-
gp100 peptide vac-cine and interleukin-2 in patients with advanced melanoma
-
Schwartzentruber, D. J., Lawson, D. H., Richards, J. M., Conry, R. M., Miller, D. M., Treisman, J., Gailani, F., Riley, L., Conlon, K., Pockaj, B., Kendra, K. L., White, R. L., Gonzalez, R., Kuzel, T. M., Curti, B., Leming, P. D., Whitman, E. D., Balkissoon, J., Reintgen, D. S., Kaufman, H., Mar-incola, F. M., Merino, M. J., Rosen-berg, S. A., Choyke, P., Vena, D., and Hwu, P. (2011). gp100 peptide vac-cine and interleukin-2 in patients with advanced melanoma. N. Engl. J. Med. 364, 2119-2127.
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 2119-2127
-
-
Schwartzentruber, D.J.1
Lawson, D.H.2
Richards, J.M.3
Conry, R.M.4
Miller, D.M.5
Treisman, J.6
Gailani, F.7
Riley, L.8
Conlon, K.9
Pockaj, B.10
Kendra, K.L.11
White, R.L.12
Gonzalez, R.13
Kuzel, T.M.14
Curti, B.15
Leming, P.D.16
Whitman, E.D.17
Balkissoon, J.18
Reintgen, D.S.19
Kaufman, H.20
Mar-incola, F.M.21
Merino, M.J.22
Rosen-berg, S.A.23
Choyke, P.24
Vena, D.25
Hwu, P.26
more..
-
103
-
-
0016836061
-
Intralesional BCG, intravenous immune lym-phocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; a clinical assessment
-
Seigler, H. F., Shingleton, W. W., and Pickrell, K. L. (1975). Intralesional BCG, intravenous immune lym-phocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; a clinical assessment. Plast. Reconstr. Surg. 55, 294-298.
-
(1975)
Plast. Reconstr. Surg.
, vol.55
, pp. 294-298
-
-
Seigler, H.F.1
Shingleton, W.W.2
Pickrell, K.L.3
-
104
-
-
84855792427
-
Cancer statistics
-
Siegel, R., Naishadham, D., and Jemal, A. (2012). Cancer statistics,2012. CA Cancer J. Clin. 62, 10-29.
-
(2012)
2012. CA Cancer J. Clin.
, vol.62
, pp. 10-29
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
105
-
-
54449097809
-
Helper T-cell responses and clin-ical activity of a melanoma vac-cine with multiple peptides from MAGE and melanocytic differenti-ation antigens
-
Slingluff, C. L. Jr., Petroni, G. R., Olson, W., Czarkowski, A., Grosh, W. W., Smolkin, M., Chianese-Bullock, K. A., Neese, P. Y., Deacon, D. H., Nail, C., Merrill, P., Fink, R., Patter-son, J. W., and Rehm, P. K. (2008). Helper T-cell responses and clin-ical activity of a melanoma vac-cine with multiple peptides from MAGE and melanocytic differenti-ation antigens. J. Clin. Oncol. 26, 4973-4980.
-
(2008)
J. Clin. Oncol.
, vol.26
, pp. 4973-4980
-
-
Slingluff Jr, C.L.1
Petroni, G.R.2
Olson, W.3
Czarkowski, A.4
Grosh, W.W.5
Smolkin, M.6
Chianese-Bullock, K.A.7
Neese, P.Y.8
Deacon, D.H.9
Nail, C.10
Merrill, P.11
Fink, R.12
Patter-son, J.W.13
Rehm, P.K.14
-
106
-
-
0141576738
-
Vaccination with irra-diated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating fac-tor by adenoviral-mediated gene transfer augments antitumor immu-nity in patients with metasta-tic melanoma
-
Soiffer, R., Hodi, F. S., Haluska, F., Jung, K., Gillessen, S., Singer, S., Tanabe, K., Duda, R., Mentzer, S., Jaklitsch, M., Bueno, R., Clift, S., Hardy, S., Neuberg, D., Mulligan, R., Webb, I., Mihm, M., and Dranoff, G. (2003). Vaccination with irra-diated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating fac-tor by adenoviral-mediated gene transfer augments antitumor immu-nity in patients with metasta-tic melanoma. J. Clin. Oncol. 21, 3343-3350.
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 3343-3350
-
-
Soiffer, R.1
Hodi, F.S.2
Haluska, F.3
Jung, K.4
Gillessen, S.5
Singer, S.6
Tanabe, K.7
Duda, R.8
Mentzer, S.9
Jaklitsch, M.10
Bueno, R.11
Clift, S.12
Hardy, S.13
Neuberg, D.14
Mulligan, R.15
Webb, I.16
Mihm, M.17
Dranoff, G.18
-
107
-
-
0028800377
-
Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function
-
Soltysik, S., Wu, J. Y., Recchia, J., Wheeler, D. A., Newman, M. J., Coughlin, R. T., and Kensil, C. R. (1995). Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vac-cine 13, 1403-1410.
-
(1995)
Vac-cine
, vol.13
, pp. 1403-1410
-
-
Soltysik, S.1
Wu, J.Y.2
Recchia, J.3
Wheeler, D.A.4
Newman, M.J.5
Coughlin, R.T.6
Kensil, C.R.7
-
108
-
-
33646255944
-
Allogeneic and autologous melanoma vaccines: where have we been and where are we going?
-
Sondak, V. K., Sabel, M. S., and Mule, J. J. (2006). Allogeneic and autologous melanoma vaccines: where have we been and where are we going? Clin. Cancer Res. 12, 2337s-2341s.
-
(2006)
Clin Cancer Res
, vol.12
-
-
Sondak, V.K.1
Sabel, M.S.2
Mule, J.J.3
-
109
-
-
84857658331
-
The role of sipuleucel-T in therapy for castration-resistant prostate cancer: a critical analysis of the literature
-
Sonpavde, G., Di Lorenzo, G., Higano, C. S., Kantoff, P. W., Madan, R., and Shore, N. D. (2012). The role of sipuleucel-T in therapy for castration-resistant prostate cancer: a critical analysis of the literature. Eur. Urol. 61, 639-647.
-
(2012)
Eur. Urol.
, vol.61
, pp. 639-647
-
-
Sonpavde, G.1
Di Lorenzo, G.2
Higano, C.S.3
Kantoff, P.W.4
Madan, R.5
Shore, N.D.6
-
110
-
-
0015619335
-
Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantita-tion, tissue distribution
-
Steinman, R. M., and Cohn, Z. A. (1973). Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantita-tion, tissue distribution. J. Exp. Med. 137, 1142-1162.
-
(1973)
J. Exp. Med.
, vol.137
, pp. 1142-1162
-
-
Steinman, R.M.1
Cohn, Z.A.2
-
111
-
-
0000810758
-
Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice
-
Steinman, R. M., and Witmer, M. D. (1978). Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. U.S.A. 75, 5132-5136.
-
(1978)
Proc. Natl. Acad. Sci. U. S. A.
, vol.75
, pp. 5132-5136
-
-
Steinman, R.M.1
Witmer, M.D.2
-
112
-
-
34547655923
-
A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment
-
Strauss, L., Bergmann, C., Szczepanski, M., Gooding, W., Johnson, J. T., and Whiteside, T. L. (2007). A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 13, 4345-4354.
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 4345-4354
-
-
Strauss, L.1
Bergmann, C.2
Szczepanski, M.3
Gooding, W.4
Johnson, J.T.5
Whiteside, T.L.6
-
113
-
-
0034679560
-
Immunologic self-tolerance main-tained by CD25(+)CD4(+) regula-tory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
-
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak,T. W.,and Sakaguchi,S. (2000). Immunologic self-tolerance main-tained by CD25(+)CD4(+) regula-tory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310.
-
(2000)
J. Exp. Med.
, vol.192
, pp. 303-310
-
-
Takahashi, T.1
Tagami, T.2
Yamazaki, S.3
Uede, T.4
Shimizu, J.5
Sakaguchi, N.6
Mak, T.W.7
Sakaguchi, S.8
-
114
-
-
33646205150
-
A molecu-lar perspective of CTLA-4 function
-
Teft, W. A., Kirchhof, M. G., and Madrenas, J. (2006). A molecu-lar perspective of CTLA-4 function. Annu. Rev. Immunol. 24, 65-97.
-
(2006)
Annu. Rev. Immunol.
, vol.24
, pp. 65-97
-
-
Teft, W.A.1
Kirchhof, M.G.2
Madrenas, J.3
-
115
-
-
34748849509
-
Vaccine therapy for melanoma: current status and future directions
-
Terando, A. M., Faries, M. B., and Mor-ton, D. L. (2007). Vaccine therapy for melanoma: current status and future directions. Vaccine 25(Suppl. 2), B4-B16.
-
(2007)
Vaccine
, vol.25
, Issue.SUPPL. 2
-
-
Terando, A.M.1
Faries, M.B.2
Mor-ton, D.L.3
-
116
-
-
39749186213
-
Phase III comparison of vitespen, an autolo-gous tumor-derived heat shock pro-tein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 study group
-
Testori, A., Richards, J., Whitman, E., Mann, G. B., Lutzky, J., Camacho, L., Parmiani, G., Tosti, G., Kirkwood, J. M., Hoos, A., Yuh, L., Gupta, R., and Srivastava,P. K. (2008). Phase III comparison of vitespen, an autolo-gous tumor-derived heat shock pro-tein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 study group. J. Clin. Oncol. 26, 955-962.
-
(2008)
J. Clin. Oncol.
, vol.26
, pp. 955-962
-
-
Testori, A.1
Richards, J.2
Whitman, E.3
Mann, G.B.4
Lutzky, J.5
Camacho, L.6
Parmiani, G.7
Tosti, G.8
Kirkwood, J.M.9
Hoos, A.10
Yuh, L.11
Gupta, R.12
Srivastava, P.K.13
-
117
-
-
0028867420
-
Loss of CTLA-4 leads to massive lympho-proliferation and fatal multiorgan tissue destruction,revealing a critical negative regulatory role of CTLA-4
-
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., and Sharpe, A. H. (1995). Loss of CTLA-4 leads to massive lympho-proliferation and fatal multiorgan tissue destruction,revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
-
(1995)
Immunity
, vol.3
, pp. 541-547
-
-
Tivol, E.A.1
Borriello, F.2
Schweitzer, A.N.3
Lynch, W.P.4
Bluestone, J.A.5
Sharpe, A.H.6
-
118
-
-
84859158384
-
Targeting the PD-1/B7-H1(PD-L1) pathway to acti-vate anti-tumor immunity
-
Topalian, S. L., Drake, C. G., and Par-doll, D. M. (2012). Targeting the PD-1/B7-H1(PD-L1) pathway to acti-vate anti-tumor immunity. Curr. Opin. Immunol. 24, 207-212.
-
(2012)
Curr. Opin. Immunol.
, vol.24
, pp. 207-212
-
-
Topalian, S.L.1
Drake, C.G.2
Par-doll, D.M.3
-
119
-
-
40649097299
-
The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine
-
Trumpfheller, C., Caskey, M., Nchinda, G., Longhi, M. P., Mizenina, O., Huang,Y.,Schlesinger,S. J.,Colonna, M., and Steinman, R. M. (2008). The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc. Natl. Acad. Sci. U.S.A. 105, 2574-2579.
-
(2008)
Proc. Natl. Acad. Sci. U. S. A.
, vol.105
, pp. 2574-2579
-
-
Trumpfheller, C.1
Caskey, M.2
Nchinda, G.3
Longhi, M.P.4
Mizenina, O.5
Huang, Y.6
Schlesinger, S.J.7
Colonna, M.8
Steinman, R.M.9
-
120
-
-
0026322151
-
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
-
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van Den Eynde, B., Knuth, A., and Boon, T. (1991). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647.
-
(1991)
Science
, vol.254
, pp. 1643-1647
-
-
van der Bruggen, P.1
Traversari, C.2
Chomez, P.3
Lurquin, C.4
De Plaen, E.5
Van Den Eynde, B.6
Knuth, A.7
Boon, T.8
-
121
-
-
38049129212
-
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
-
Vence, L., Palucka, A. K., Fay, J. W., Ito, T., Liu, Y. J., Banchereau, J., and Ueno, H. (2007). Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma. Proc. Natl. Acad. Sci. U.S.A. 104, 20884-20889.
-
(2007)
Proc. Natl. Acad. Sci. U. S. A.
, vol.104
, pp. 20884-20889
-
-
Vence, L.1
Palucka, A.K.2
Fay, J.W.3
Ito, T.4
Liu, Y.J.5
Banchereau, J.6
Ueno, H.7
-
122
-
-
34248172345
-
Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes
-
von Euw, E. M., Barrio, M. M., Furman, D.,Bianchini,M.,Levy,E. M.,Yee,C., Li, Y., Wainstok, R., and Mordoh, J. (2007). Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes. J. Transl. Med. 5, 19.
-
(2007)
J. Transl. Med.
, vol.5
, pp. 19
-
-
von Euw, E.M.1
Barrio, M.M.2
Furman, D.3
Bianchini, M.4
Levy, E.M.5
Yee, C.6
Li, Y.7
Wainstok, R.8
Mordoh, J.9
-
123
-
-
40749136181
-
A phase I clinical study of vacci-nation of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells, Analysis of toxicity and immune response to the vaccine and of IL-10-1082 promoter genotype as predic-tor of disease progression
-
von Euw, E. M., Barrio, M. M., Fur-man, D., Levy, E. M., Bianchini, M., Peguillet, I., Lantz, O., Vellice, A., Kohan, A., Chacon, M., Yee, C., Wainstok, R., and Mordoh, J. (2008). A phase I clinical study of vacci-nation of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predic-tor of disease progression. J. Transl. Med. 6, 6.
-
(2008)
J. Transl. Med.
, vol.6
, pp. 6
-
-
von Euw, E.M.1
Barrio, M.M.2
Fur-man, D.3
Levy, E.M.4
Bianchini, M.5
Peguillet, I.6
Lantz, O.7
Vellice, A.8
Kohan, A.9
Chacon, M.10
Yee, C.11
Wainstok, R.12
Mordoh, J.13
-
124
-
-
1642497640
-
Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy
-
Wang, H. Y., Lee, D. A., Peng, G., Guo, Z., Li, Y., Kiniwa, Y., Shevach, E. M., and Wang, R. F. (2004). Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20, 107-118.
-
(2004)
Immunity
, vol.20
, pp. 107-118
-
-
Wang, H.Y.1
Lee, D.A.2
Peng, G.3
Guo, Z.4
Li, Y.5
Kiniwa, Y.6
Shevach, E.M.7
Wang, R.F.8
-
125
-
-
0030472678
-
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
-
Wang, R. F., Appella, E., Kawakami, Y., Kang, X., and Rosenberg, S. A. (1996). Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. Exp. Med. 184, 2207-2216.
-
(1996)
J. Exp. Med.
, vol.184
, pp. 2207-2216
-
-
Wang, R.F.1
Appella, E.2
Kawakami, Y.3
Kang, X.4
Rosenberg, S.A.5
-
126
-
-
0028791059
-
Lymphopro-liferative disorders with early lethal-ity in mice deficient in Ctla-4
-
Waterhouse,P.,Penninger,J. M.,Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., and Mak, T. W. (1995). Lymphopro-liferative disorders with early lethal-ity in mice deficient in Ctla-4. Science 270, 985-988.
-
(1995)
Science
, vol.270
, pp. 985-988
-
-
Waterhouse, P.1
Penninger, J.M.2
Timms, E.3
Wakeham, A.4
Shahinian, A.5
Lee, K.P.6
Thompson, C.B.7
Griesser, H.8
Mak, T.W.9
-
127
-
-
84862135169
-
What are regula-tory T cells (Treg) regulating in can-cer and why?
-
doi: 10.1016/j.semcancer.2012.03.004
-
Whiteside,T. L. (2012).What are regula-tory T cells (Treg) regulating in can-cer and why? Semin. Cancer Biol. doi: 10.1016/j.semcancer.2012.03.004
-
(2012)
Semin Cancer Biol
-
-
Whiteside, T.L.1
-
128
-
-
53749094183
-
CTLA-4 control over Foxp3+ regulatory T cell function
-
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., and Sakaguchi, S. (2008). CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271-275.
-
(2008)
Science
, vol.322
, pp. 271-275
-
-
Wing, K.1
Onishi, Y.2
Prieto-Martin, P.3
Yamaguchi, T.4
Miyara, M.5
Fehervari, Z.6
Nomura, T.7
Sakaguchi, S.8
-
129
-
-
78650439466
-
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials
-
Wolchok, J. D., Weber, J. S., Hamid, O., Lebbe, C., Maio, M., Schadendorf, D., De Pril, V., Heller, K., Chen, T. T., Ibrahim, R., Hoos, A., and O'Day, S. J. (2010). Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials. Cancer Immun. 10, 9.
-
(2010)
Cancer Immun
, vol.10
, pp. 9
-
-
Wolchok, J.D.1
Weber, J.S.2
Hamid, O.3
Lebbe, C.4
Maio, M.5
Schadendorf, D.6
De Pril, V.7
Heller, K.8
Chen, T.T.9
Ibrahim, R.10
Hoos, A.11
O'Day, S.J.12
-
130
-
-
33645286546
-
Regulatory T cells, tumour immunity and immunotherapy
-
Zou, W. (2006). Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6, 295-307.
-
(2006)
Nat. Rev. Immunol.
, vol.6
, pp. 295-307
-
-
Zou, W.1
|